Proximity Ligation Assay (PLA) Meets PTMs: A Cutting-Edge Tool for Protein Research and ANT BIO PTE. LTD.'s Antibody Solutions

1. Concept: Post-Translational Modifications (PTMs) and Proximity Ligation Assay (PLA)

Post-translational modifications (PTMs) are reversible chemical alterations that occur after protein synthesis, finely tuning protein structure, function, localization, stability, and molecular interactions. Common PTMs include phosphorylation, glycosylation, ubiquitination, and acetylation, which regulate essential cellular processes such as signaling cascades, metabolism, cell cycle progression, and immune responses. Dysregulated PTMs are closely linked to disease pathogenesis, including cancer, autoimmune disorders, and neurodegenerative diseases.

The Proximity Ligation Assay (PLA), developed by Navinci (Sweden), is a highly sensitive and specific technique for studying protein interactions and PTMs in situ. Its core principle relies on proximity-dependent signal amplification: when two target epitopes (e.g., a PTM site and a protein-specific epitope) are within 40 nm, oligonucleotide-conjugated antibody pairs bind to them, enabling ligation of the oligonucleotides into a circular DNA template. Rolling Circle Amplification (RCA) generates long single-stranded DNA with repeated sequences, which hybridize to fluorescent probes for detection. This technology enables qualitative and quantitative analysis of PTMs and protein complexes at endogenous levels, overcoming limitations of traditional methods like Western blot or immunofluorescence.

2. Research Frontiers of PLA-PTM Combined Studies

Contemporary research on the integration of PLA and PTM studies focuses on expanding analytical capabilities and translational applications. A key frontier is the development of multiplex PLA assays to simultaneously detect multiple PTMs on a single protein or across protein complexes. Another prominent direction involves applying PLA-PTM approaches to clinical samples, enabling the detection of disease-specific PTM signatures for diagnostic and prognostic purposes. Additionally, research is optimizing PLA protocols for high-throughput screening, facilitating the identification of PTM regulators (e.g., kinases, deacetylases) in drug discovery. Furthermore, the combination of PLA with super-resolution microscopy is advancing the spatial mapping of PTMs in subcellular compartments.

3. Research Significance of PLA-PTM Studies

The integration of PLA and PTM research holds profound implications for molecular biology and translational science:

• Sensitive PTM detection: PLA enables the detection of low-abundance PTMs and transient protein complexes that are undetectable by conventional methods.
• Spatial resolution: Provides in situ visualization of PTMs, revealing their subcellular localization and context within biological systems.
• Disease biomarker discovery: Disease-specific PTM patterns detected via PLA offer potential diagnostic and prognostic biomarkers.
• Drug target validation: Facilitates the identification and validation of PTM-related enzymes (e.g., kinases) as therapeutic targets.
• Mechanistic insights: Uncovers the role of PTMs in protein-protein interactions and signaling pathways, deepening understanding of disease mechanisms.

4. Relevant Mechanisms, Research Methods and Product Applications

4.1 Core Mechanisms of PTMs and PLA Technology

Key PTM Functions

• Phosphorylation: Mediated by kinases, regulates protein activity and signaling (e.g., Akt, mTOR phosphorylation in cancer).
• Ubiquitination: Tags proteins for proteasomal degradation (e.g., tumor suppressor ubiquitination in cancer progression).
• Glycosylation: Enhances protein stability and modulates cell-cell interactions.
• Acetylation: Regulates transcription factor activity and chromatin structure.

PLA Experimental Workflow

1. Antibody binding: Two oligonucleotide-conjugated antibodies bind to the target protein and its PTM site (e.g., phosphorylated residue).
2. Ligation: When the antibodies are in proximity (<40 nm), DNA ligase connects the oligonucleotides to form a circular template.
3. Amplification: RCA amplifies the circular DNA, generating a long single-stranded DNA with repeated sequences.
4. Detection: Fluorescent probes hybridize to the amplified DNA, and signals are visualized via fluorescence microscopy.

4.2 PLA-PTM Application Examples

Phosphorylated HER2 Detection

PLA specifically detects phosphorylated HER2 (p-HER2) in cancer cells, using anti-HER2 and anti-phosphotyrosine antibodies. The fluorescent signal (TEX615) correlates with p-HER2 levels, enabling the assessment of HER2 activation status.

Phosphorylated EGFR Detection

Similarly, PLA detects phosphorylated EGFR (p-EGFR) using target-specific and phosphotyrosine antibodies, providing insights into EGFR signaling activation in tumors.

4.3 Product Applications of ANT BIO PTE. LTD.

ANT BIO PTE. LTD. delivers high-specificity PTM-targeted antibodies for PLA and other applications through its Starter sub-brand—specializing in recombinant antibodies. All products are validated for sensitivity, specificity, and compatibility with PLA, complying with EU 98/79/EC, ISO9001, and ISO13485 certifications. Key offerings include:

• Phosphorylation-specific antibodies:
• Phospho-Akt (Ser473) Recombinant Rabbit mAbs (S0B0611, S0B0596): $100 each.
• Phospho-mTOR (Ser2448) Recombinant Rabbit mAb (S0B0597): $100.
• Phospho-Stat1 (Tyr701) Recombinant Rabbit mAb (S0B0748): Inquiry.
• Phospho-IκBα (Ser32/36) Recombinant Rabbit mAb (S0B0631): Inquiry.
• Ubiquitination antibody:
• Ubiquitin Recombinant Rabbit mAb (S0B0087): $100.
• Protein-specific antibodies:
• EGFR (L858R) Recombinant Rabbit mAb (S0B2355): Inquiry.

These antibodies pair seamlessly with NavinciFlex kits, enabling the detection of diverse PTMs (phosphorylation, ubiquitination) via PLA. They support basic research, drug discovery, and clinical sample analysis.

5. Brand Mission of ANT BIO PTE. LTD.

ANT BIO PTE. LTD. is dedicated to empowering global life science research and clinical practice through high-quality, innovative reagents and professional services. As a leading provider of life science solutions, the company offers a comprehensive portfolio including antibodies, recombinant proteins, ELISA kits, and general laboratory reagents, with three specialized sub-brands: Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins). Leveraging advanced R&D platforms—including recombinant antibody development (rabbit/mouse monoclonal), protein expression systems (E.coli, CHO, HEK293, Insect Cells), One-Step ELISA, and PTM Pan-Modification Antibody platforms—ANT BIO PTE. LTD. adheres to the principles of "precision, reliability, and customer-centricity." The company strives to deliver cost-effective products and tailored support to researchers, clinicians, and biopharmaceutical partners, accelerating the translation of scientific discoveries into improved patient care and advancing molecular biology research.

6. Related Product List

7. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.